Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
Initiation of coagulation cascade
Summary
- Organism
- Homo sapiens (human)
- Reactome
- R-HSA-9769735
- PubChem
- R-HSA-9769735
- Description
-
- The initiation phase of coagulation proceeds through the tissue factor (TF)-mediated generation of a small amount of thrombin on the plasma membrane surfaces of TF-bearing cells (e.g., fibroblasts, smooth muscle cells and pericytes) (reviewed by Rao LVM & Pendurthi UR 2012; Grover SP & Mackman N 2018). Additionally, activated cells (e.g., polarized macrophages) and apoptotic cells, along with certain cancer cells, release TF-bearing extracellular vesicles (EVs) with procoagulant activity (Hohensinner PJ et al., 2021; reviewed by Hisada Y et al., 2022; Sachetto ATA et al., 2023). TF is predominantly maintained in a cryptic, coagulant-inactive state on the surfaces of resting cells or EVs (Schecter AD et al. 1997; Bach RR 2006; Kothari H et al. 2013; Grover SP & Mackman N 2018). Upon tissue injury or inflammation TF is converted into its procoagulant isoform at the membrane surface. Ca²⁺-dependent exposure of phosphatidylserine (PS), hydrolysis of sphingomyelin (SM) and thiol-disulfide exchange within TF are thought to synergistically contribute to the activation of TF on the outer plasma membrane (Langer F & Ruf W 2014; Ansari SA et al. 2019). Activated TF becomes exposed to circulating blood and the extracellular part of TF binds both the zymogen factor VII (FVII) and its active serine protease form FVIIa with very high affinity and specificity (Vadivel K& Bajaj SP 2012; Prasad R & Sen P 2018). The TF:FVIIa complex initiates the coagulation protease cascade by converting zymogens FIX and FX to active proteases FIXa and FXa, which are involved in the generation of thrombin.
Aberrant expression of TF is associated with various coagulopathies. For example, the procoagulant properties of EVs bearing TF may contribute to thrombosis and disseminated intravascular coagulation in pathophysiologic conditions such as cancer, sepsis, and infection (reviewed by Mackman N et al., 2021; Hisada Y et al., 2022; Sachetto ATA et al., 2023).
- The initiation phase of coagulation proceeds through the tissue factor (TF)-mediated generation of a small amount of thrombin on the plasma membrane surfaces of TF-bearing cells (e.g., fibroblasts, smooth muscle cells and pericytes) (reviewed by Rao LVM & Pendurthi UR 2012; Grover SP & Mackman N 2018). Additionally, activated cells (e.g., polarized macrophages) and apoptotic cells, along with certain cancer cells, release TF-bearing extracellular vesicles (EVs) with procoagulant activity (Hohensinner PJ et al., 2021; reviewed by Hisada Y et al., 2022; Sachetto ATA et al., 2023). TF is predominantly maintained in a cryptic, coagulant-inactive state on the surfaces of resting cells or EVs (Schecter AD et al. 1997; Bach RR 2006; Kothari H et al. 2013; Grover SP & Mackman N 2018). Upon tissue injury or inflammation TF is converted into its procoagulant isoform at the membrane surface. Ca²⁺-dependent exposure of phosphatidylserine (PS), hydrolysis of sphingomyelin (SM) and thiol-disulfide exchange within TF are thought to synergistically contribute to the activation of TF on the outer plasma membrane (Langer F & Ruf W 2014; Ansari SA et al. 2019). Activated TF becomes exposed to circulating blood and the extracellular part of TF binds both the zymogen factor VII (FVII) and its active serine protease form FVIIa with very high affinity and specificity (Vadivel K& Bajaj SP 2012; Prasad R & Sen P 2018). The TF:FVIIa complex initiates the coagulation protease cascade by converting zymogens FIX and FX to active proteases FIXa and FXa, which are involved in the generation of thrombin.
Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.
| UniProt ID | Protein Name | Gene Symbol | Pathway Viewer |
|---|---|---|---|
| O00468 | Agrin |
|
view |
| O75056 | Syndecan-3 |
|
view |
| O75487 | Glypican-4 |
|
view |
| P00451 | Coagulation factor VIII |
|
view |
| P00734 | Prothrombin |
|
view |
| P00740 | Coagulation factor IX |
|
view |
| P00742 | Coagulation factor X |
|
view |
| P01008 | Antithrombin-III |
|
view |
| P04275 | von Willebrand factor |
|
view |
| P07225 | Vitamin K-dependent protein S |
|
view |
